| In 1952, a drug called chlorpromazine was the first | | | | Tardive Dyskinesia Today |
| drug of its kind introduced to treat psychotic | | | | Today, different governmental research organizations |
| patients. After its introduction, many other | | | | support a wide variety of studies on movement |
| anti-psychotic drugs were added into the treatments | | | | disorders like TD in order to increase understanding, |
| of patients suffering from psychotic disorders. These | | | | improve treatment options, and find cures. |
| drugs are called neuroleptics and are major | | | | Researchers have found that TD among patients |
| tranquilizers. | | | | who receive anti-psychotic medications can occur |
| However, four years later, researchers and medical | | | | from 0.5% to 56% of the time. On average, 25% of |
| experts discovered the risks of neuroleptics. They | | | | patients who receive anti-psychotic treatment are |
| found that chlorpromazine and related drugs can | | | | diagnosed with TD. |
| movement disorders, causing patients to exhibit | | | | TD can sometimes be treated with other |
| repetitive, involuntary, uncontrollable movements. At | | | | medications, or might stop if the patient stops taking |
| first, health practitioners did not fully understand the | | | | neuroleptic drugs. However, in some cases, even |
| relationship between the involuntary movements and | | | | ceasing treatment is not effective, and the disorder |
| the treatment, since sometimes these types of | | | | can become permanent over time. Patients |
| movements and mannerisms are already exhibited by | | | | prescribed neuroleptic-containing drugs should consider |
| persons with psychiatric disorders. However, over | | | | if the negative symptoms of their neurological |
| times, medical experts realized that drug-induced | | | | disorder outweigh the risks of treatment options that |
| movement disorders have become a growing | | | | can cause medical problems like TD. |
| problem in clinical psychiatry. | | | | Recent research efforts often focus on the |
| Neuroleptic-Related Disorders | | | | prevalence of TD among young children and |
| The condition associated with these involuntary, | | | | adolescents. Some researchers believe that children |
| repetitive motions is referred to as Tardive | | | | have a much higher sensitivity to certain side effects |
| dyskinesia (TD). Features of TD might include: | | | | of neuroleptic drugs than do adults. In addition, some |
| - Rapid blinking of the eyes | | | | studies look at the risks of TD in infants and |
| - Grimacing | | | | newborn children whose mothers had been treated |
| - Sticking out the tongue | | | | for psychiatric disorders. Especially when children are |
| - Smacking, puckering, or pursing lips. | | | | involved, early treatment and diagnoses of the |
| - Rapid movements in the arms, legs, and fingers | | | | condition is essential. |
| Researchers believe that TD occurs because of | | | | To learn more about tardive dyskinesia and other |
| damage that neuroleptics can cause to dopamine | | | | neurological-related disorders, visit the website of |
| neurotransmitter systems. | | | | Reglan child injury attorneys of Williams Kherkher. |